Trends in performance of ERCP among patients with surgically unresectable pancreatic cancer: a Survival, Epidemiology and End Results–Medicare database study

Keyphrases

• Epidemiology 100%
• Pancreatic Adenocarcinoma 100%
• Database Study 100%
• Resectable Pancreatic Cancer 100%
• Surveillance Epidemiology 66%
• Cancer Diagnosis 66%
• Inclusion Criteria 33%
• Cholestasis 33%
• Systemic Chemotherapy 33%
• Stent Placement 33%
• Exclusion Criteria 33%
• Decompression 33%
• 1-year Survival 33%
• Biliary Obstruction 33%
• Bile Duct 33%
• P for Trend 33%
• Pancreas Cancer 33%
• Medicare Population 33%
• Latent Factor Analysis 33%
• Biliary Stent 33%
• Pancreas Surgery 33%

Medicine and Dentistry

• Pancreas Cancer 100%
• Cohort Effect 100%
• Endoscopic Retrograde Cholangiopancreatography 100%
• Adenocarcinoma 16%
• Surveillance, Epidemiology, and End Results 16%
• Cancer Diagnosis 16%
• Cholestasis 16%
• Medicare 8%
• Pancreas Adenocarcinoma 8%
• Stent Placement 8%
• Bile Duct 8%
• Pancreas Surgery 8%
• Exclusion Criterion 8%